لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Betschel SD; Clinical Immunology and Allergy, Department of Medicine, University of Toronto, Toronto, ON, Canada. Stephen.Betschel@unityhealth.to., Caballero T; Servicio de Alergia, Hospital Universitario la Paz, CIBERER U754, IdiPAZ Group 44, Madrid, Spain., Jones DH; Rocky Mountain Allergy at Tanner Clinic, Layton, Utah, USA., Longhurst HJ; Department of Medicine, University of Auckland and Auckland City Hospital, Te Toka Tumai, Auckland, New Zealand., Manning M; Allergy, Asthma & Immunology Associates, Ltd., Internal Medicine, UA College of Medicine-Phoenix, Scottsdale, AZ, USA., van Kooten S; KalVista Pharmaceuticals, Inc, Cambridge, MA, USA., Heckmann M; KalVista Pharmaceuticals, Inc, Cambridge, MA, USA., Danese S; Outcomes Insights, Agoura Hills, CA, USA., Goga L; Division of Allergy and Immunology, Howard University Hospital, Washington, DC, USA., Burnette AF; Department Division Director Clinical Immunology and Allergy, Staff Clinical Immunologist and Allergist, University of Toronto, St. Michael's Hospital, 36 Toronto St, Suite 700, Toronto, ON, M5C 2C5, Canada.

المصدر: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology [Allergy Asthma Clin Immunol] 2024 Jul 25; Vol. 20 (1), pp. 43. Date of Electronic Publication: 2024 Jul 25.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Country of Publication: England NLM ID: 101244313 Publication Model: Electronic Cited Medium: Print ISSN: 1710-1484 (Print) Linking ISSN: 17101484 NLM ISO Abbreviation: Allergy Asthma Clin Immunol Subsets: PubMed not MEDLINE

المؤلفون: Burnette AF; Division of Allergy and Immunology, Howard University Hospital, Washington, DC.

المصدر: International forum of allergy & rhinology [Int Forum Allergy Rhinol] 2021 Jun; Vol. 11 (6), pp. 965-966. Date of Electronic Publication: 2021 Jan 13.

نوع المنشور: Editorial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Published for ARS-AAOA by Wiley-Blackwell Country of Publication: United States NLM ID: 101550261 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2042-6984 (Electronic) Linking ISSN: 20426976 NLM ISO Abbreviation: Int Forum Allergy Rhinol Subsets: MEDLINE

مواضيع طبية MeSH: Angioedemas, Hereditary*/diagnosis , Angioedemas, Hereditary*/prevention & control, Humans

المؤلفون: LaFleur DW; Zyngenia, Inc., Gaithersburg, MD, USA. dlafleur@zyngenia.com, Abramyan D, Kanakaraj P, Smith RG, Shah RR, Wang G, Yao XT, Kankanala S, Boyd E, Zaritskaya L, Nam V, Puffer BA, Buasen P, Kaithamana S, Burnette AF, Krishnamurthy R, Patel D, Roschke VV, Kiener PA, Hilbert DM, Barbas CF 3rd

المصدر: MAbs [MAbs] 2013 Mar-Apr; Vol. 5 (2), pp. 208-18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101479829 Publication Model: Print Cited Medium: Internet ISSN: 1942-0870 (Electronic) Linking ISSN: 19420862 NLM ISO Abbreviation: MAbs Subsets: MEDLINE

مواضيع طبية MeSH: Antibody Specificity*, Antibodies, Monoclonal/*therapeutic use , Neoplasms/*therapy , Peptides/*therapeutic use , Recombinant Fusion Proteins/*therapeutic use, Amino Acid Sequence ; Angiopoietin-2/chemistry ; Angiopoietin-2/genetics ; Angiopoietin-2/immunology ; Animals ; Antibodies, Bispecific/genetics ; Antibodies, Bispecific/immunology ; Antibodies, Bispecific/metabolism ; Antibodies, Bispecific/therapeutic use ; Antibodies, Monoclonal/genetics ; Antibodies, Monoclonal/immunology ; Antibodies, Monoclonal/metabolism ; Antibodies, Monoclonal, Humanized/immunology ; Antibodies, Monoclonal, Humanized/therapeutic use ; Cell Proliferation/drug effects ; Cetuximab ; Female ; Humans ; Mice ; Mice, Inbred NOD ; Mice, SCID ; Molecular Sequence Data ; Neovascularization, Pathologic ; Peptides/genetics ; Peptides/immunology ; Peptides/metabolism ; Protein Engineering/methods ; Receptor, ErbB-2/chemistry ; Receptor, ErbB-2/genetics ; Receptor, ErbB-2/immunology ; Recombinant Fusion Proteins/genetics ; Recombinant Fusion Proteins/immunology ; Signal Transduction ; Trastuzumab ; Treatment Outcome ; Xenograft Model Antitumor Assays